KR20170083706A - Fermented garlic by lactic acid bacteria and Food Composition consisting thereof - Google Patents
Fermented garlic by lactic acid bacteria and Food Composition consisting thereof Download PDFInfo
- Publication number
- KR20170083706A KR20170083706A KR1020160002882A KR20160002882A KR20170083706A KR 20170083706 A KR20170083706 A KR 20170083706A KR 1020160002882 A KR1020160002882 A KR 1020160002882A KR 20160002882 A KR20160002882 A KR 20160002882A KR 20170083706 A KR20170083706 A KR 20170083706A
- Authority
- KR
- South Korea
- Prior art keywords
- lactic acid
- garlic
- fermented
- acid bacteria
- fermentation
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 134
- 235000004611 garlic Nutrition 0.000 title claims abstract description 86
- 239000004310 lactic acid Substances 0.000 title claims abstract description 67
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 67
- 241000894006 Bacteria Species 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims description 16
- 235000013305 food Nutrition 0.000 title claims description 9
- 244000245420 ail Species 0.000 title 1
- 240000002234 Allium sativum Species 0.000 claims abstract description 85
- 238000000855 fermentation Methods 0.000 claims abstract description 27
- 230000004151 fermentation Effects 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 26
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 6
- 240000001929 Lactobacillus brevis Species 0.000 claims abstract description 6
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 6
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 6
- 239000008103 glucose Substances 0.000 claims abstract description 6
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 6
- 238000001035 drying Methods 0.000 claims abstract description 5
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims abstract description 4
- 239000006872 mrs medium Substances 0.000 claims abstract description 3
- 230000002401 inhibitory effect Effects 0.000 claims description 13
- CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- 102100024295 Maltase-glucoamylase Human genes 0.000 claims description 3
- 108010028144 alpha-Glucosidases Proteins 0.000 claims description 3
- 230000001766 physiological effect Effects 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000000701 coagulant Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 238000007602 hot air drying Methods 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 13
- 241000383638 Allium nigrum Species 0.000 description 10
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 9
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 9
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000006000 Garlic extract Substances 0.000 description 2
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 2
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000020706 garlic extract Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- AAXWBCKQYLBQKY-IRXDYDNUSA-N (2s)-2-[[(2s)-2-[(2-benzamidoacetyl)amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-4-methylpentanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)C=1C=CC=CC=1)C1=CN=CN1 AAXWBCKQYLBQKY-IRXDYDNUSA-N 0.000 description 1
- KJTLQQUUPVSXIM-ZCFIWIBFSA-M (R)-mevalonate Chemical compound OCC[C@](O)(C)CC([O-])=O KJTLQQUUPVSXIM-ZCFIWIBFSA-M 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 101710152519 3-hydroxy-3-methylglutaryl-coenzyme A reductase 2 Proteins 0.000 description 1
- IFBHRQDFSNCLOZ-IIRVCBMXSA-N 4-nitrophenyl-α-d-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-IIRVCBMXSA-N 0.000 description 1
- 101000719121 Arabidopsis thaliana Protein MEI2-like 1 Proteins 0.000 description 1
- 101000797612 Arabidopsis thaliana Protein MEI2-like 3 Proteins 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 108010079362 Core Binding Factor Alpha 3 Subunit Proteins 0.000 description 1
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 101000857677 Homo sapiens Runt-related transcription factor 1 Proteins 0.000 description 1
- 101000857682 Homo sapiens Runt-related transcription factor 2 Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- GFXYTQPNNXGICT-YFKPBYRVSA-N L-allysine Chemical compound OC(=O)[C@@H](N)CCCC=O GFXYTQPNNXGICT-YFKPBYRVSA-N 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 102100025373 Runt-related transcription factor 1 Human genes 0.000 description 1
- 102100025368 Runt-related transcription factor 2 Human genes 0.000 description 1
- 102100025369 Runt-related transcription factor 3 Human genes 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 229940029982 garlic powder Drugs 0.000 description 1
- 108010016268 hippuryl-histidyl-leucine Proteins 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000036454 renin-angiotensin system Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000021262 sour milk Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A23Y2220/13—
-
- A23Y2220/67—
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Preparation Of Fruits And Vegetables (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a method for producing lactic acid fermented garlic by fermentation process using lactic acid bacteria after hot air drying without using garlic, and furthermore, to a fermented garlic of lactic acid bacteria prepared by the method, more specifically, (a) slicing and drying with hot air to remove moisture; (b) separately cultivating Lactobacillus brevis and Lactobacillus plantarum in an MRS medium and shaking culture at 37 ° C and 120 rpm for 2 days; (c) inoculating the dried garlic obtained in step (a) with 30% (w / w) of the cultured lactic acid bacterium obtained in step (b) to regulate moisture; (d) preparing a fermentation broth by adding 1 to 3% of hydrolyzed glucose to the fermentation broth through fermentation at 37 ° C for 4 days to allow fermentation without lactic acid bacteria being killed; (e) drying the fermented garlic of lactic acid bacteria obtained in the above step again with hot air to increase the functionality of garlic.
Description
The present invention relates to a fermented garlic food using lactic acid bacteria, and more particularly to a fermented garlic food composition of lactic acid bacteria fermented with lactic acid bacteria in hot air-dried garlic.
The present invention relates to a method for producing fermented garlic through lactic acid fermentation using garlic. Garlic (garlic) is native to Central Asia, Egypt baekhwagwa plants are commonly grown and smells unique flavor throughout. The main effects of garlic are sterilization, anticancer effect, antimicrobial effect, alleviation of anemia and hypotension, and garlic has been registered as a functional ingredient of health functional food as cholesterol improving effect. Currently, only fermentation method using black garlic is the process of producing fermented garlic.
Black garlic is a method in which raw garlic is placed in a hot and humid place on the skin and matured for 15 to 20 days. Conventionally, the method of fermenting black garlic generally involves fermenting black garlic and subjecting it to natural fermentation. However, when garlic is fermented, the fermentation of the fermentation microorganism is inhibited by the antibacterial action of the garlic ingredient allysine.
Taking this into consideration, a composition for preventing or treating obesity or hyperlipidemia (Registration No. 10-0990260) including fermented black garlic extract as an active ingredient is known as a prior art. In the process of producing fermented black garlic, black garlic was first extracted with distilled water or organic solvent, and then the yeast ( Saccharomyces cerevisiae < CTC 7910 >). This is because after the black garlic extracting step, the black germ extract is inoculated in a malt medium (M medium), cultured at 28 ° C for 2 to 3 days, and a part of yeast-containing residues obtained by centrifuging the first culture BG medium and incubated at 28 ° C for 2 ~ 3 days, there is a complicated process from black garlic extraction stage to yeast fermentation stage and a long fermentation period of 7 days or more, which causes a defect accompanied with excessive manpower and cost.
Accordingly, it is an object of the present invention to provide a garlic fermented with hot-air-dried garlic directly with lactic acid bacteria in consideration of the disadvantage of the yeast two-stage fermentation method of the black garlic extract.
It is another object of the present invention to provide a food composition comprising fermented garlic as an active ingredient using the lactic acid bacterium single fermentation process.
The above object of the present invention is achieved by a method for producing garlic, comprising the steps of: (a) slicing garlic and removing it by hot air drying; (b) Separately, MRS medium supplemented with Lactobacillus brevis , Lactobacillus plantarum Inoculated and cultured for 2 days at 37 ° C and 120 rpm with shaking; (c) inoculating 30% (w / w) of the culture solution of lactic acid bacteria into the dried garlic obtained in the step (a) to regulate moisture; (d) preparing a fermentation broth by adding 1 to 3% of hydrolyzed glucose to the fermentation broth through fermentation at 37 ° C for 4 days to allow fermentation without lactic acid bacteria being killed; (e) drying the fermented garlic lactic acid bacteria obtained in the above step again by hot air drying.
The present invention provides a food composition containing fermented garlic wherein garlic is dried and fermented with lactic acid bacteria to increase the functionality of garlic.
1 is a flow chart of a method for producing fermented garlic lactic acid bacteria according to an embodiment of the present invention.
2 is a graph showing the results of total polyphenol concentration of lactic acid fermented garlic of the present invention.
3 is a graph showing the results of total flavonoid concentration of lactic acid fermented garlic of the present invention.
4 is a graph showing the DPPH inhibitory activity of the lactic acid fermented garlic of the present invention, which is an antioxidative activity.
5 is a graph showing the results of HMG-CoA inhibition activity of lactic acid fermented garlic.
6 is a graph showing the results of ACE inhibition activity of lactic acid fermented garlic.
7 is a graph showing the results of a-glucosidase inhibitory activity of lactic acid fermented garlic.
The present invention provides a fermented garlic powder composition using lactic acid bacteria.
The fermented garlic of the present invention contains lactic acid bacteria Lactobacillus brevis And Lactobacillus plantarum to produce a fermented product.
According to the present invention, the lactic acid bacteria used in the above may be commercially available.
In addition, the lactic acid bacteria used in their real names are advantageous because they inhibit the fermentation of acetic acid by the lactic acid bacteria on the equilibrium anaerobic side. Therefore, Lactobacillus acidophilus was not preferred among lactic acid bacteria.
The lactic acid bacteria used in the present invention may be used alone or in a mixed ratio of 1: 1.
The fermented garlic composition may be manufactured from functional foods, cosmetics, pharmaceuticals and the like.
The present invention will be described in more detail with reference to the following specific examples and test examples. However, the following examples and test examples are for illustrative purposes only and are not intended to limit the scope of the present invention.
Example 1. Production of lactic acid bacteria culture
In the MRS liquid medium, Lactobacillus brevis , Lactobacillus plantarum After inoculation, the cells were cultured for 2 days at 37 ° C and 120 rpm with shaking, and then, water-soluble glucose was added as shown in Table 1 below and used as a fermentation broth.
Example 2. Production of lactic acid fermented garlic
The skin-removed garlic is subjected to slicing treatment with a thickness of 5 to 10 mm after washing to remove impurities in distilled water and washing water. The sliced garlic is put into a hot air dryer and dried at 50 ~ 70 ~ 24 ~ 48hrs to remove moisture. The hot-air dried garlic is subjected to fermentation preparation by inoculating 30% (W / V) of the culture solution of lactic acid bacteria to control the water content. Fermented lactic acid bacteria fermented in a fermenter after fermentation for 4 days at a temperature of 35 ~ 37 ℃ and a humidity of 80 ~ 95%. The fermented garlic is heated again in a hot air dryer at 50 to 70 ° C for 24 to 48 hours to have a moisture content of 13% or less (FIG. 1).
Example 3. Manufacture of lactic acid bacteria fermented garlic prototype
Using the fermented garlic lactic acid produced according to the method of Example 1, a prototype was prepared in the ratio shown in Table 2 below.
Experimental Example 1. Physiological Activity Test of Fermented Garlic of Lactic Acid Bacteria According to the Invention
The total flavonoid content of the lactic acid fermented garlic prepared according to the method of Example 2 and the lactic acid fermented garlic product prepared according to the method of Example 3 was measured by the modified Davis method (Chae et al ., 2002 ). To 400 μL of sample, 4 mL of 90% diethylene glycol was added and 40 μL of 1 N NaOH was added. After reacting at 37 ° C. for 1 hour, absorbance was measured at 420 nm. Rutin was used as a reference material.
As shown in FIG. 2, the total flavonoid content of the fermented garlic lactic acid bacteria was 395.88 ppm, which was higher than that of the control garlic (control) of 171.35 ppm.
Total polyphenol content was measured by Folin-Denis method (Swain et al., 1959). That is, 1 mL of a 2% Na 2 CO 3 solution was added to 50 μL of the supernatant by centrifugation, 50 μL of Folin &Ciocalteu's phenol reagents were mixed, and the mixture was reacted at room temperature for 30 minutes and absorbance was measured at 760 nm. Tannic acid (Sigma co., USA) was used as a reference material and the total polyphenol content was calculated from the calibration curve prepared by the same method as the sample.
As a result, as shown in FIG. 3, the total polyphenol content of the fermented garlic lactic acid bacteria was 678.55 ppm, which was higher than that of the control garlic (control) of 286.05 ppm.
Experimental Example 2. Antioxidant Activity Test of Fermented Garlic of Lactic Acid Bacteria of the Invention
DPPH activity was measured as follows in the antioxidation of the lactic acid fermented garlic prepared according to the method of Example 2 of the present invention and the lactic acid fermented garlic prototype prepared according to the method of Example 3 as follows. In the experiment, 1 mL of 200M DPPH and 1 mL of the sample were mixed and reacted at 37 ° C for 30 minutes in a dark place, and the absorbance at 517 nm was measured.
The DPPH radical scavenging activity (%) was calculated by the following equation. As a result, DPPH antioxidation measurement results of the lactic acid fermented garlic prototype were 102% of the prototype and higher than that of the control garlic (control) of 37% as shown in FIG. 4.
[Equation 1]
Experimental Example 3. ACE-I Inhibition Activity Assay of Fermented Garlic of Lactic Acid Bacterium according to the Invention
The renin-angiotensin system plays an important role in the cause of hypertension. The angiotensin-converting enzyme (ACE) is involved in the hypertension, and fermented garlic lactic acid produced according to the method of Example 2 of the present invention and the method of Example 3 The ACE inhibitory effect of lactic acid bacteria fermented garlic was investigated by Cushman and Cheung [1971]. Biochem. Phamacol.] As follows. 100 uL of a solution in which 12.5 mM of Hip-His-Leu was dissolved in 0.1 M sodium borate buffer (pH 8.3) containing 0.4 M NaCl, 100 uL of ACE and 50 uL of a sample were mixed and reacted at 37 ° C for 30 minutes. Lt; / RTI > Ethylacetate was added to extract the reaction product, and the reaction product was completely dried. Absorbance was measured at 229 nm by adding distilled water to the dried material, and the ACE inhibition rate (%) was calculated by the following equation (2). Because hypertension in humans is caused by ACE, hypertension can be prevented if it can inhibit the activity of ACE.
As shown in FIG. 5, the ACE inhibitory activity of lactic acid fermented garlic was 96.66% higher than that of the control dry garlic (control) of 80%, and that of lactic acid fermented garlic was 96.66%.
[Equation 2]
Experimental Example 4. The fermented garlic of the present invention HMG - CoA Inhibition activity assay
HMG-CoA reductase is an enzyme necessary to reduce HMG-CoA to mevalonate and is a key enzyme involved in cholesterol biosynthesis. HMG-CoA reductase inhibition can lower the level of cholesterol in the blood, thereby improving blood flow. CoA reductase assay kit (Sigma-Aldrich) using the lactic acid fermented garlic prepared according to the method of Example 2 above and the lactic acid fermented garlic prototype prepared according to the method of Example 3 were used to prepare Sun Antimicro., ≪ / RTI > Chemother). Each sample was mixed with 10 uL, NADPH 4 uL, HMG-CoA 12 uL, and HMG-CoA reductase 2 uL, and then reacted at 37 ° C for 10 min to measure the absorbance at 340 nm in UV-spectrometer. The inhibitory activity rate was expressed by the following formula 2. As shown in FIG. 6, the HMG-CoA inhibitory activity of fermented garlic lactic acid bacteria was higher than that of the control garlic (control) of 0.004 mmol / min / mg-protein, Inhibitory activity. The inhibition rate of HMG-CoA activity was calculated according to the following formula 3.
[Equation 3]
Experimental Example 5. The fermented garlic of the present invention, glucosidase Inhibition activity assay
The inhibitory effect of? -Glucosidase activity was measured using the lactic acid fermented garlic prepared according to the method of Example 2 and the lactic acid fermented garlic prototype prepared according to the method of Example 3.
The inhibitory effect of α-Glucosidase activity was measured according to the method of Tibbot et al. (1996). The substrate solution was prepared at a concentration of 1 mg / mL by dissolving ρ-nitrophenol-α-D-glucopyranoside (PNPG, Sigma) in 50 mM sodium phosphate buffer (pH 4.2). The enzyme reaction was performed in 100 mL of substrate solution and 0.05
[Equation 4]
As shown in FIG. 7, the α-glucosidase inhibitory activity of the fermented garlic lactic acid bacteria was found to be higher than that of the control garlic (control) of 32% by 107%.
Industrial Applicability As described above, the present invention provides a method for fermenting dried garlic by fermenting garlic with fermented garlic by the above-mentioned method, Is a very useful invention that can be applied to functional foods, cosmetics, and medicines.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160002882A KR101915807B1 (en) | 2016-01-08 | 2016-01-08 | Fermented garlic by lactic acid bacteria and Food Composition consisting thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160002882A KR101915807B1 (en) | 2016-01-08 | 2016-01-08 | Fermented garlic by lactic acid bacteria and Food Composition consisting thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170083706A true KR20170083706A (en) | 2017-07-19 |
KR101915807B1 KR101915807B1 (en) | 2018-11-07 |
Family
ID=59427498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160002882A KR101915807B1 (en) | 2016-01-08 | 2016-01-08 | Fermented garlic by lactic acid bacteria and Food Composition consisting thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101915807B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109504636A (en) * | 2018-12-27 | 2019-03-22 | 内蒙古农业大学 | A kind of lactobacillus plantarum P12 and application thereof |
KR20210028388A (en) * | 2019-09-04 | 2021-03-12 | 윤심 | Method for producing fermented garlic composition of lactic acid bacteria |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024127377A1 (en) * | 2022-12-16 | 2024-06-20 | Tim Richards | Fermentation and dehydration processes for novel postbiotic fermented foods |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100716133B1 (en) | 2006-08-17 | 2007-05-08 | 주식회사 신원에프아이 | Health-improving garlic ingredient having reduced pungent flavor and method for the preparation thereof |
KR101173903B1 (en) * | 2012-02-24 | 2012-08-16 | (재)남해마늘연구소 | Manufacturing method of garlic fermentation liquid |
-
2016
- 2016-01-08 KR KR1020160002882A patent/KR101915807B1/en active IP Right Grant
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109504636A (en) * | 2018-12-27 | 2019-03-22 | 内蒙古农业大学 | A kind of lactobacillus plantarum P12 and application thereof |
KR20210028388A (en) * | 2019-09-04 | 2021-03-12 | 윤심 | Method for producing fermented garlic composition of lactic acid bacteria |
Also Published As
Publication number | Publication date |
---|---|
KR101915807B1 (en) | 2018-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102223806B (en) | Method for preparing fermented tea using bacillus genus strain | |
KR101082246B1 (en) | Nuruk containing salicornia herbacea and preparation method of the same | |
CN107080008A (en) | A kind of natural pile fermentation of golden flower Pu'er cooked teas loose tea is grown dim method | |
KR101915807B1 (en) | Fermented garlic by lactic acid bacteria and Food Composition consisting thereof | |
Wang et al. | Nutritional value and volatiles of the edible mushroom Leucocalocybe mongolica | |
KR20210073948A (en) | Method of manufacturing fermented by-products of Cirsium setidens nakai having increased immuno activity and easy chewability | |
CN102321540B (en) | Preparation method of lactic acid Amphibacillus fermentation liquor, and preparation method of lactic acid Amphibacillus fermentation liquor composite antiseptic by using fermentation liquor thereof | |
KR20200080629A (en) | Manufacturing method for edible enzyme food using Bacillus sbutilis | |
KR100635529B1 (en) | Fermented beverage containing anti-oxidant materials and a method thereof | |
CN101756241B (en) | Tea live-bacteria food and preparation method thereof | |
KR102183814B1 (en) | Preparation method of liquid culture of Lentinus edode mycelia and the liquid culture of Lentinus edode mycelia | |
CN115251203B (en) | Application of Xie Washi aspergillus in preparing peony petal tea by fermentation and method | |
CN111388515A (en) | Method for liquid fermentation of ginseng by monascus, ginseng fermentation product and application | |
KR101814941B1 (en) | Food composition for anti-oxidation comprising cockscomb flower extract short-term fermented by lactic acid bacteria and the method of preparation thereof | |
CN102199545B (en) | Lachnum singerianum, and method for preparing intracellular melanin through liquid fermentation of lachnum singerianum | |
KR101391284B1 (en) | Novel lactobacillus plantarum to-2100, fermentation method of mulberry leaves using thereby, fermented materials thereby and food composition comprising the fermented materials | |
KR20160079388A (en) | Korean Traditional Meju Prepared by Modified Process and Manufacturing Method of Doenjang and Soy Sauce Using the Same | |
KR20160125618A (en) | Manufacturing Method for Biogenics using Vegetable Lactobacllus | |
KR20160074300A (en) | Method of Making Material for Health Food by Fermentation of Medical Herbs | |
KR101381950B1 (en) | Fermented tea of persimmon leaf and manufacturing method of the same | |
KR100927573B1 (en) | A method of preparing seed cell for natto using Bacillus subtilis BN-NUC1(KCCM-10839P) | |
CN109363058A (en) | The biodegradation method of vomitoxin in a kind of pair of corn pulp | |
CN103060205A (en) | Active mold inhibitor, as well as preparation method and application thereof | |
KR102713506B1 (en) | method for prepairing of fermented velvet antler slices using solid state fermentation | |
CN112725222B (en) | Bacillus subtilis Q3 for producing complex enzyme, culture method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |